MedTrace Logo

Magnetic Resonance Imaging (MRI) Brachytherapy Applicator Study

NCT01706705 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2022-02-23

Study results available
· View outcomes & findings →

Summary

The goal of this clinical research study is to learn if computed tomography (CT) and magnetic resonance imaging (MRI) images can better help to plan internal radiation treatment.

Conditions

Interventions

DEVICE

Intracavitary Applicator Placement

MRI-compatible applicator inserted using ultrasound guidance to verify tandem placement in the uterus. Tandem and ovoids, tandem and cylinders, or tandem and ring chosen to accommodate patient's tumor and vaginal anatomy.

OTHER

Computed Tomography (CT)

CT scan performed after implant is placed in operating room. CT scan should take about 20 minutes.

OTHER

Magnetic Resonance Imaging (MRI)

MRI scan performed after implant is placed in the operating room. MRI should take about 45 minutes.

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Ann Klopp, MD · M.D. Anderson Cancer Center

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-22
Primary Completion
2018-04-22
Completion
2018-04-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01706705 on ClinicalTrials.gov